Olink Proteomics AB Sustainability Profile
Olink Proteomics AB, a leading player in the field of proteomics, is headquartered in Uppsala, Sweden. Founded in 2016, the company has rapidly established itself as a pioneer in the development of innovative protein biomarker discovery solutions. Olink's unique Proximity Extension Assay (PEA) technology enables high-throughput, multiplexed protein analysis, setting it apart in the competitive landscape of life sciences. With a strong presence in Europe and North America, Olink serves a diverse clientele, including academic institutions and pharmaceutical companies. The company has achieved significant milestones, including partnerships with major research organisations, which underscore its commitment to advancing precision medicine. Olink's core offerings, such as the Olink Explore and Olink Target platforms, are designed to provide researchers with unparalleled insights into protein interactions and functions, solidifying its position as a trusted leader in the proteomics industry.
DitchCarbon Score
How does Olink Proteomics AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Olink Proteomics AB's score of 97 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Olink Proteomics AB, headquartered in Sweden (SE), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Thermo Fisher Scientific Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. Olink Proteomics AB has not outlined any specific reduction targets or initiatives in its own right. However, it is important to note that the climate commitments and performance metrics may be influenced by the sustainability strategies of Thermo Fisher Scientific Inc. This includes adherence to initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Thermo Fisher Scientific Inc. at a corporate family level. As a subsidiary, Olink Proteomics AB may align its climate strategies with those of Thermo Fisher Scientific Inc., which is actively engaged in reducing its carbon footprint and enhancing sustainability practices across its operations. However, without specific emissions data or reduction targets from Olink itself, a detailed assessment of its individual climate commitments remains unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 321,190,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 486,151,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Olink Proteomics AB's Industry?
How Carbon Intensive is Olink Proteomics AB's Location?
Olink Proteomics AB's Scope 3 Categories Breakdown
Olink Proteomics AB's Scope 3 emissions, which decreased by 26% last year and decreased by approximately 37% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 58% of Scope 3 emissions.
Top Scope 3 Categories
Olink Proteomics AB's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Olink Proteomics AB has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
